Early Detection of Kidney Disease Using Ensemble Learning and Feature Engineering Techniques
摘要
Kidney disease poses a significant global health challenge, necessitating innovative approaches for early detection and intervention. This study delves into the realm of predictive analytics through the utilization of machine learning algorithms to enhance kidney disease risk assessment. The research employs a comprehensive dataset comprising clinical and demographic variables, fostering a robust analysis of potential risk factors. The initial phase involves a systematic exploration of the dataset, employing statistical methods to identify correlations and patterns within the data. Subsequently, a comparative analysis of various machine learning algorithms, including but not limited to support vector machines, decision trees, and ensemble methods, is undertaken. Development of hybrid algorithm for kidney disease prediction using machine learning involves combining different techniques to improve accuracy, robustness or efficiency in predicting this condition. This evaluation aims to pinpoint the most effective model in terms of accuracy, sensitivity, and specificity in predicting kidney disease onset. The model development phase focuses on the implementation of the chosen machine learning model, incorporating features that contribute significantly to predictive accuracy. The model undergoes rigorous validation using distinct datasets to ensure its generalizability and reliability. Additionally, interpretability and transparency are prioritized to enhance the model's clinical applicability and acceptance. The study's findings provide valuable insights into the identification and understanding of key predictors of kidney disease, offering a potential tool for early diagnosis and intervention. The integration of machine learning in kidney disease prediction not only aids healthcare professionals in risk stratification but also contributes to the broader landscape of predictive analytics in preventive healthcare. The implications of this research extend to improving patient outcomes, reducing healthcare costs, and fostering a proactive approach to managing kidney disease on a global scale.